Stugeron

Cinnarizine

Cinnarizine 25mg tablets, a calcium channel blocker and antihistamine used to treat motion sickness and vertigo.

All strengths and pack prices
Stugeron: price of every strength and pack size
Strength Pack Price
25mg 50 tablets $72.00
25mg 100 tablets $102.00
25mg 150 tablets $103.50
Active ingredient
Cinnarizine
Route
Oral
Form
Tablet
Strengths
25mg

You will receive a quality generic equivalent, depending on stock.

Shipped in a discreet, unmarked envelope.

Details

Conditions
Motion sickness · Vertigo
Therapeutic Class
Antihistamine
Pharmacological Class
Calcium channel blocker
Minor Side Effects
Drowsiness, Weight gain
Moderate Side Effects
Stomach discomfort
Dosage Forms
Tablet
Administration Route
Oral
Originator
Janssen
Onset Time
1–2 hours
Duration
8 hours
Storage Instructions
Room temperature.
Drug Interactions
Alcohol, Sedatives
Age Restrictions
Caution in elderly.

What you will receive

Stugeron is the originator brand name, made by Janssen. We use it to identify the medicine; the pack you receive is a generic equivalent, not the original Stugeron.

  • The same active ingredient (Cinnarizine) at the same strength.
  • The exact brand supplied depends on what is in stock when your order ships.

FAQ

What pack sizes of Stugeron are available?

Stugeron comes as generic cinnarizine 25mg tablets in packs of 50, 100 or 150. This is generic cinnarizine, not the original Stugeron. Larger packs cost less per tablet.

Is a Stugeron parcel discreet?

Yes. Every Stugeron order ships in plain, unbranded packaging with nothing on the outside about the contents. Payment is by Visa, Mastercard or American Express on a secure, encrypted page, or by Bitcoin or Ethereum, and card details never reach our servers.

What other names is cinnarizine sold under?

Stugeron is a brand name of cinnarizine, which is also sold as Vertigon. Here, cinnarizine can be bought online as generic Stugeron. These are generics, not the original brand.

Can Stugeron be used to prevent seasickness before a cruise?

Yes, taking a 25 mg pill of Stugeron before boarding can help reduce the likelihood of motion-induced nausea. The medication should be taken, typically 30 minutes before exposure to motion.

Is it appropriate to take Stugeron with other antihistamines for allergy relief?

Combining Stugeron with additional antihistamines can increase sedation and anticholinergic effects.

What should I do if I feel excessive drowsiness while taking Stugeron?

Adjusting the time of day the medication is taken may mitigate this side effect.

Does Stugeron have any impact on blood pressure?

Cinnarizine’s calcium-channel blocking activity can cause mild vasodilation, but it is not typically used to treat hypertension and usually does not produce clinically significant blood-pressure changes.

Is Stugeron detectable in drug-screening tests for athletes?

Cinnarizine is not listed as a prohibited substance by major sports anti-doping agencies, but athletes should verify current regulations with their governing bodies before use.

Are there any known interactions between Stugeron and alcohol?

Alcohol can amplify the sedative effects of Stugeron, leading to increased drowsiness. Moderate or avoid alcohol consumption while taking the medication.

What are the differences between Stugeron and other motion-sickness drugs like meclizine?

Both contain antihistaminic properties, but cinnarizine (Stugeron) also strongly blocks calcium channels, which may provide additional vestibular stabilization.

About Stugeron

What is Cinnarizine?

Operating as a calcium channel blocker, Cinnarizine modulates the influx of calcium ions into the smooth muscle cells of the inner ear. This substance is the active compound found in Stugeron, where it functions to stabilize the vestibular system. Its primary role involves addressing disturbances in balance and symptoms resulting from motion sensitivity.

The chemical structure of this antihistamine derivative allows it to cross the blood-brain barrier to exert its effects. By reducing the flow of calcium, the compound diminishes the excitability of the labyrinthine system. Patients frequently encounter this molecule in formulations intended to manage episodic dizziness and related inner ear discomforts.

Clinical applications of this ingredient centre on its ability to dampen the signals of imbalance reaching the brain. While it is classified as a piperazine-derivative antihistamine, its unique pharmacological profile distinguishes it from agents used primarily for allergies.

Formulations and Associated Products

Cinnarizine is the core substance within the Stugeron brand, which is a common item in many Hong Kong pharmacies. Available primarily as oral tablets, the compound is designed for systemic absorption to address inner ear sensitivity.

Because various generic versions of these formulations exist in the market, patients often find the ingredient listed under different trade names. Regardless of the branding, the active molecule remains consistent across these preparations. Whether presented as a standard immediate-release oral tablet or a specialized oral formulation, the intended physiological focus remains the coordination of balance.

Therapeutic Applications

  • Motion Sensitivity: The compound addresses feelings of discomfort, nausea, and unsteadiness caused by travel in vehicles, vessels, or aircraft.
  • Vestibular Disaccess requests: It manages symptoms of vertigo, including the sensation of room-spinning, which often arises from inner ear disturbances.
  • Meniere’s Disease Symptoms: The substance assists in moderating the ringing in the ears (tinnitus) and associated dizziness linked to fluid pressure changes in the ear.
  • Nystagmus Management: Physicians may apply this ingredient to reduce the involuntary, rapid eye movements characteristic of certain vestibular conditions.
  • Balance Rehabilitation: In cases of persistent instability, this agent is utilized to support the stabilization of sensory input paths during the recovery phase.

Mechanism of Biological Action

Upon ingestion, the molecule manoeuvres to the semicircular canals of the inner ear, where it inhibits the contraction of muscular components. By blocking calcium channels, it lowers the sensitivity of micro-nerves that signal movement to the brain. This intervention acts as a digital filter, smoothing out the erratic signals that would otherwise trigger a sensation of vertigo or nausea. Furthermore, it exerts a mild vascular benefit in the local region, supporting a balanced neuro-muscular environment.

Risk Profile

Common Reactions

Patients may occasionally experience temporary sleepiness or a mild sense of fatigue shortly after intake. Dryness of the mouth is another frequently observed minor response that typically resolves as the body adjusts to the substance.

Serious Reactions

Immediate clinical attention is required if there are signs of an allergic response, such as sudden skin rashes, itching, or swelling of the face and throat. Any unexpected tremors or stiffening of muscles that follow the intake of this compound should be reported promptly to a medical professional.

Contraindications

Individuals with pre-existing movement disorders or those experiencing significant symptoms of conditions like Parkinson’s disease require extra caution. Pregnant patients and those breastfeeding are advised to avoid this substance unless specifically directed otherwise by a clinical practitioner.

Interaction Awareness

Combining this ingredient with alcohol or other central nervous system suppressants may significantly enhance feelings of drowsiness.

Usage Context and Considerations

The duration of use typically depends on the nature of the condition, ranging from short-term usage during travel to managed intervals for chronic vestibular concerns. Proper storage involves keeping the tablets in a cool, dry place away from direct light to maintain the integrity of the active molecule. For Stugeron-specific instructions, refer to the medication information supplied with the product.

Glossary

Labyrinthine: Relates to the complex system of canals and cavities within the inner ear responsible for balance and hearing.

Vestibular: Pertaining to the sensory system that provides the brain with information about motion, head position, and spatial orientation.

Calcium Channel Blocker: A class of substances that slow or prevent the movement of calcium through cell membranes and into the cells.

Nystagmus: A condition characterized by rapid, involuntary, and rhythmic movement of the eyes.

Sources

  1. Stugeron 15mg Tablets - Summary of Product Characteristics (SmPC) - (emc) — electronic medicines compendium (emc)
  2. Cinnarizine: antihistamine used for travel sickness and vertigo - NHS — NHS